Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04629326
NA
PD-L1 Targeting Molecular Imaging of Solid Tumors
Sponsor: Peking University Cancer Hospital & Institute
View on ClinicalTrials.gov
Summary
The objective of the study is to constrcut a noninvasive approach WL12 PET/CT to detect the PD-L1 expression of tumor lesions in patients with gastrointestinal tumors and to identify patients benefiting from anti-PD-1/L1 treatment.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2021-07-20
Completion Date
2024-11
Last Updated
2024-08-19
Healthy Volunteers
No
Conditions
Interventions
OTHER
68Ga-WL12 PET/CT
WL12, labeled with PET radio-nuclide ( Ga-68 )will be used as a molecular imaging tracer for PET/CT scanning
Locations (1)
Beijing Cancer Hospital
Beijing, Beijing Municipality, China